Chlorin e6 conjugated silica nanoparticles for targeted and effective photodynamic therapy

Photodiagnosis Photodyn Ther. 2017 Sep:19:212-220. doi: 10.1016/j.pdpdt.2017.06.001. Epub 2017 Jun 3.

Abstract

Photodynamic therapy (PDT) using photosensitizer drug has become an important therapeutic modality. However, the stability and targeted delivery of photosensitizer remain a critical challenge for efficient PDT treatment. In the present study, we developed chlorin e6 (Ce6)-conjugated and folic acid (FA)-decorated silica nanoparticles (silica-Ce6-FA) for targeted delivery of photosensitizer to the cancer cells. The synthesized NPs exhibited excellent stability and biocompatibility with MDA-MB-231 cells. The formulated particles were efficiently taken up by folate receptor-positive MDA-MB-231 cells, which were confirmed by comparative analysis with folate receptor-negative HepG2 cells. The folate receptor-targeted silica-Ce6-FA was highly accumulated inside the MDA-MB-231 cells than free Ce6. The obtained NPs produced singlet oxygen efficiently under 670-nm laser exposure. The cell-killing effect of silica-Ce6-FA was higher when compared with free Ce6 under PDT treatment. The PDT-induced mitochondrial damage and apoptotic cell death were detected in silica-Ce6-FA-treated cells.

Keywords: Apoptosis; Folic acid; Photodynamic; Photosensitizer; Silica.

MeSH terms

  • Apoptosis / drug effects
  • Chlorophyllides
  • Drug Stability
  • Folic Acid / chemistry
  • Hep G2 Cells
  • Humans
  • Nanoparticles / chemistry*
  • Particle Size
  • Photochemotherapy / methods*
  • Photosensitizing Agents / administration & dosage
  • Photosensitizing Agents / pharmacology*
  • Porphyrins / administration & dosage
  • Porphyrins / pharmacology*
  • Reactive Oxygen Species / metabolism
  • Silicon Dioxide / chemistry
  • Surface Properties

Substances

  • Chlorophyllides
  • Photosensitizing Agents
  • Porphyrins
  • Reactive Oxygen Species
  • phytochlorin
  • Silicon Dioxide
  • Folic Acid